Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Kidney pathological pathways" is not a specific molecule or receptor but rather a broad term referring to the various cellular and molecular processes that contribute to kidney disease, such as chronic kidney disease (CKD) or diabetic kidney disease. These pathways include networks involving inflammation, fibrosis, metabolic changes, cell death, immune responses, and signaling by cytokines, chemokines, and growth factors[5][6][8]. Numerous specific targets within these pathways (e.g., receptors, enzymes, ion channels) have been investigated for therapeutic intervention, but "kidney pathological pathways" itself does not correspond to a single, discrete target in biomedical research or drug development[8]. Thus, this entry is considered incorrect for the purpose of listing molecular targets or receptors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kidney pathological pathways.